Development and characterization of novel 2'-F-RNA aptamers specific to human total and glycated hemoglobins.


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 11 12 2018
revised: 05 02 2019
accepted: 06 02 2019
pubmed: 12 2 2019
medline: 18 12 2019
entrez: 12 2 2019
Statut: ppublish

Résumé

Aptamers are short DNA and RNA fragments which bind their molecular targets with affinity and specificity comparable to those of antibodies. Here, we describe the selection of novel 2'-F-RNA aptamers against total human hemoglobin or its glycated form HbA1c. After SELEX and high-throughput sequencing of the enriched libraries, affinities and specificities of candidate aptamers and their truncated variants were examined by the solid-phase bioluminescent assay. As a result, we identified aptamers specific to both hemoglobins or only glycated HbA1c. The developed 2'-F-RNA aptamers have shown their applicability for detection of total and glycated hemoglobin in one sample.

Identifiants

pubmed: 30742800
pii: S0003-2697(18)31232-6
doi: 10.1016/j.ab.2019.02.004
pii:
doi:

Substances chimiques

Aptamers, Nucleotide 0
Glycated Hemoglobin A 0
Hemoglobins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-50

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Anna Davydova (A)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia. Electronic address: anna.davydova@niboch.nsc.ru.

Mariya Vorobyeva (M)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Eugenia Bashmakova (E)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Institute of Biophysics SB RAS, Federal Research Center "Krasnoyarsk Science Center SB RAS", Krasnoyarsk, Russia.

Pavel Vorobjev (P)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Department of Natural Sciences, Novosibirsk State University, Pirogova St., 2, 630090, Novosibirsk, Russia.

Olga Krasheninina (O)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Alexey Tupikin (A)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Marsel Kabilov (M)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Vasilisa Krasitskaya (V)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Institute of Biophysics SB RAS, Federal Research Center "Krasnoyarsk Science Center SB RAS", Krasnoyarsk, Russia.

Ludmila Frank (L)

Institute of Biophysics SB RAS, Federal Research Center "Krasnoyarsk Science Center SB RAS", Krasnoyarsk, Russia; Siberian Federal University, Krasnoyarsk, 660041, Russia.

Alya Venyaminova (A)

Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH